Marty Makary’s hold on the top job at FDA is slipping, with White House leaks about President Donald Trump’s displeasure with the FDA commissioner shifting the question from whether he will be fired to when. On the latest BioCentury This Week podcast, Washington Editor Steve Usdin discusses the pressures on Makary, how long he will hold onto his post, and the leading candidates to succeed him.
BioCentury’s analysts then discuss solutions to AAV’s redosing problem, which could reignite industry interest in a modality that has fallen out of favor, and other topics in the spotlight at this week’s American Society of Gene and Cell Therapy annual meeting. The analysts also discuss opportunities to attend and present academic posters at the third BioCentury Grand Rounds U.S. conference June 3-5 in Seattle. This episode of the BioCentury This Week podcast has been brought to you by Jeito Capital.

View full story: https://www.biocentury.com/article/659426

#FDA #GeneTherapy #AAV #CellTherapy #Biopharma

00:01 - Sponsor Message: Jeito Capital
01:43 - Bio€quity Europe Prague Highlights
04:54 - Makary on Thin Ice
14:37 - Grand Rounds Poster Pitch
16:40 - AAVs at ASGCT

To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com.

Reach us by sending a text

Ep. 365 - Thin ice for Makary, redosing AAVs

BioCentury This Week

Ep. 365 - Thin ice for Makary, redosing AAVs